Funder
National Institutes of Health
University of Tennessee, Center of Excellence in Livestock Diseases and Human Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference53 articles.
1. Marotti JD, de Abreu FB, Wells WA, Tsongalis GJ (2017) Triple-negative breast cancer: next-generation sequencing for target identification. Am J Pathol 187:2133–2138. https://doi.org/10.1016/j.ajpath.2017.05.018
2. Nakhjavani M, Hardingham JE, Palethorpe HM, Price TJ, Townsend AR (2019) Druggable molecular targets for the treatment of triple negative breast cancer. J Breast Cancer 22:341–361. https://doi.org/10.4048/jbc.2019.22.e39
3. Chang-Qing Y, Jie L, Shi-Qi Z, Kun Z, Zi-Qian G, Ran X, Hui-Meng L, Ren-Bin Z, Gang Z, Da-Chuan Y, Chen-Yan Z (2020) Recent treatment progress of triple negative breast cancer. Prog Biophys Mol Biol 151:40–53. https://doi.org/10.1016/j.pbiomolbio.2019.11.007
4. Breast Cancer Risk in American Women, National Cancer Institute, National Institutes of Health. https://www.cancer.gov/types/breast/risk-fact-sheet (Accessed 2020)
5. Cancer Facts and Figures 2020, American Cancer Society. http://www.cancer.org/research/cancerfactsfigures/index (Accessed 2020)
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献